Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The time is getting close for more news r/t EHR----Obama said "top priority"

I believe we will start to see some additional successes for Crossflo in the next quarter or two also. Let's hope so anyway.

But remember as RG stated in the CC, I believe, the expected REVENUE..not earnings, for the calendar year was about $6MM....so we may be looking at only $2-3MM revenue for our Fiscal year (10K report).

Hopefully, 2010 will show a marked improvement on those numbers and maybe even a profit by then too. We really don't know what to expect yet for a profit margin on Crossflo, but I am assuming once the ball starts to roll on this venture our profits could be double or triple what the earnings are forecasted to be for 2009.



JMHO

Share
New Message
Please login to post a reply